In addition, FABP5 has been identified as a crucial prognostic factor in various tumors, including lung adenocarcinoma (LUAD), clear cell renal cell carcinoma (ccRCC), and multiple myeloma (MM), among others 41, 42. This evidence concerns the gene FABP5 and AL amyloidosis.